The Center for AIDS Intervention Research (CAIR ), an NIMH-funded center directed by Dr. Jeffrey Kelly, concentrates on the study of individuals belonging to groups at high risk for HIV infection (e.g. gay men, IV drug users, chronic mentally ill) and the development of behavioral interventions to decrease this behavior. Presently, CAIR consists of more than 30 full time faculty and staff and has an annual budget of more than $8 million. MCW is a world leader in the field of behavioral intervention research to prevent the spread of HIV infection.
Current ongoing research focuses on utilizing clinical and multimodal imaging to enhance the understanding of the neurobiological mechanisms that link depression with Alzheimer’s disease.
Joseph S. Goveas, MD, is an Associate Professor in the Department of Psychiatry and Behavioral Medicine and the Institute of Health and Society at the Medical College of Wisconsin. Dr. Goveas is a fellowship-trained Geriatric Psychiatrist and is the Director of the Geriatric Psychiatry fellowship program and clinics at the Medical College. He is a past recipient of a young investigator award from the National Alliance for Research on Schizophrenia and Depression (NARSAD), a pilot grant from the Extendicare Foundation, and a grant from the Advancing a Healthier Wisconsin Endowment to the Medical College. He currently serves as the principal investigator of an Alzheimer’s Association New Investigator Research award and principal investigator on another recently awarded Extendicare Foundation grant.
Dr. Goveas’ research interests are to identify changes in brain neuronal networks that occur in late-life depression, mild cognitive impairment as an approach to increased understanding of the interactions between depression and memory loss in the elderly.
If you are interested in becoming a participant in one of his studies, please contact the study coordinator, Stacy Claesges, at (414) 955-8970 or via email at email@example.com.
Harold H. Harsch, MD, is a Professor in the Department of Psychiatry and Behavioral Medicine and serves as the principal investigator for the Clinical Trials Office. Dr. Harsch has an FDA approved Humanitarian Use Device; the Medtronic Reclaim Deep Brain Stimulation for Obsessive-Compulsive Disorder. If you are interested in finding out more information, please contact the study coordinator, Stacy Claesges, at (414) 955-8970 or via email at firstname.lastname@example.org.